Bayer Aktiengesellschaft (BAYRY) Projected to Post Earnings on Tuesday

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) is anticipated to release its results before the market opens on Tuesday, November 11th. Analysts expect Bayer Aktiengesellschaft to post earnings of $0.13 per share and revenue of $11.3055 billion for the quarter.

Bayer Aktiengesellschaft Stock Performance

OTCMKTS BAYRY opened at $7.57 on Monday. The company has a market cap of $29.75 billion, a P/E ratio of -7.80, a PEG ratio of 3.62 and a beta of 0.84. The company has a fifty day simple moving average of $8.03 and a 200 day simple moving average of $7.71. The company has a current ratio of 1.13, a quick ratio of 0.73 and a debt-to-equity ratio of 1.04. Bayer Aktiengesellschaft has a 12-month low of $4.79 and a 12-month high of $8.70.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on BAYRY shares. Zacks Research cut shares of Bayer Aktiengesellschaft from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 19th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.